World Genotyping Market - Opportunities and Forecasts, 2018-2025

Genotyping is the process of studying DNA sequence to determine genetic constitution in the genotypes of living organisms, such as humans, plants, animals, and microorganisms. Human genotyping helps in determining fatherhood or motherhood. Genotyping of micro-organisms, including viruses and bacteria, helps in prevention of spreading of pathogens by tracking down the origin of outbreak. Traditionally, genotyping was partial due to technological limitations, which means doctors and scientists were able to determine only small fraction of genotype. But, technological advancements in recent years present new avenues in the genotyping process by providing whole-genome genotyping.

The factors that drive the growth of the world genotyping market are decreasing prices of DNA sequencing, increasing incidence of genetic diseases, growing importance of SNP genotyping in drug development, awareness on personalized medicine, and increasing demand for genotyping of animal & plant livestock. However, ambiguity in the reimbursement for these products and a lack of trained professional are factors that restrain the growth of this market. Increasing application areas of genotyping and increasing investments by key manufacturers create opportunities in the market.

The world genotyping market is segmented based on products & services, technology, applications, end users, and geography. The market is further segmented based on products & services into reagents & kits, genotyping services, instruments (sequencer & amplifiers and analyzers), and bioinformatics software. The market is further segmented on the basis of technology into microarrays, capillary electrophoresis (AFLP, RFLP, and SSCP), polymerase chain reaction (PCR) (real-time and digital), sequencing (Next-Generation Sequencing, pyrosequencing, and sanger sequencing), MALDI-TOF, allele specific oligonucleotide (ASO) probes, and others.

The world genotyping market is further categorized based on applications into pharmacogenomics, animal genetics, diagnostic research, agricultural biotechnology, and others. Furthermore, the market is segmented based on end users into pharmaceutical & biopharmaceutical companies, diagnostic & research laboratories, and academic institutes.

The genotyping market is further categorized based on geography into North America, Asia-Pacific, Europe, and Rest of the World (RoW). The North American market is further classified into Canada and U.S. The Asia-Pacific market is further segmented into China, Japan, India, and the Rest of the Asia (RoA). The European region is further divided into France, Italy, Spain, Germany, U.K., and Rest of the Europe (RoE). The Rest of the World includes Middle East & Africa, and Latin America.

The key manufacturers profiled in the report are Affymetrix Inc., Illumina Inc., Sequenom Inc., Thermo Fisher Scientific Inc., Agilent Technologies, QIAGEN N.V., Beckman Coulter, Roche, GE Healthcare, and Fluidigm Corporation. Various strategies such as mergers & acquisitions, expansions, and new product launches are implemented by these manufacturers to gain presence in the market.

KEY BENEFITS FOR STAKEHOLDERS:

The report offers a detailed analysis of key driving and restraining factors of the world genotyping market.

The report provides an in-depth analysis of current and future market status of the world genotyping market.

This report offers an extensive quantitative analysis of the current market and estimations through 2015-2020, which assists in identifying the prevailing market opportunities.

The key manufacturers within the world genotyping market are profiled in the report and their strategies have been studied thoroughly.

The competitive landscape analysis in report helps in understanding the competitive environment across geographies.

Geographically, the world genotyping market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

An in-depth analysis of current research and clinical developments within the world genotyping market helps in understanding the behaviour of the market.

KEY MARKET SEGMENTS:

By Products & Services

Reagents & Kits

Genotyping Services

Bioinformatics Software

Instruments

Sequencer & Amplifiers

Analyzers

By Technology

Microarrays

Capillary Electrophoresis

Amplified Fragment Length Polymorphism (AFLP)

Restriction Fragment Length Polymorphism (RFLP)

Single-Strand Conformation Polymorphism (SSCP)

Polymerase Chain Reaction (PCR)

Real-Time PCR

Digital PCR

Sequencing

Next-Generation Sequencing

Pyrosequencing

Sanger Sequencing

MALDI-TOF

Allele Specific Oligonucleotide (ASO) Probes

Others

By Applications

Pharmacogenomics

Animal Genetics

Diagnostic Research

Agricultural Biotechnology

Others

By End User

Pharmaceutical & Biopharmaceutical Companies

Diagnostic & Research Laboratories

Academic Institutes

By Geography

North America

Canada

U.S.A.

Asia-Pacific

China

Japan

India

Rest of the Asia

Europe

France

Italy

Spain

Germany

U.K.

Rest of the Europe

Rest of the World (RoW)

Middle East & Africa

Latin America

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR)
encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only
engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates
and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within
each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors
and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis
and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and
allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning

Technologically sophisticated and reliable insights through well audited and veracious research methodology

Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to:
Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.